Latest Ratios: P/E Ratio 10.1x · EV/EBITDA 6.2x · ROE 0.3%. (2018–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.2B | $7.5B | $6.5B | $4.3B | $3.1B | $3.7B | — | — | — |
| Enterprise Value | $8.2B | $6.4B | $4.7B | $5.6B | $3.2B | $5.1B | — | — | — |
| P/E Ratio → | 10.12 | — | 7.42 | 4.76 | 0.50 | 1.17 | — | — | — |
| P/S Ratio | 1.38 | 1.12 | 2.10 | 1.35 | 0.32 | 0.67 | — | — | — |
| P/B Ratio | 0.90 | 0.72 | 0.65 | 0.41 | 0.33 | 0.33 | — | — | — |
| P/FCF | 1.56 | 1.30 | 1.12 | 0.81 | 0.59 | 0.65 | — | — | — |
| P/OCF | 1.61 | 1.30 | 1.12 | 0.81 | 0.59 | 0.65 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.96 | 1.54 | 1.77 | 0.32 | 0.93 | — | — | — |
| EV / EBITDA | 6.20 | — | 4.23 | 5.26 | 0.40 | 1.18 | — | — | — |
| EV / EBIT | — | — | 4.23 | 5.26 | 0.40 | 1.17 | — | — | — |
| EV / FCF | — | 1.11 | 0.82 | 1.06 | 0.61 | 0.90 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.5% | 85.5% | 77.3% | 77.9% | 91.6% | 90.7% | -25.8% | 8.4% | 25.9% |
| Operating Margin | -1.7% | -1.7% | 33.1% | 30.3% | 79.6% | 79.0% | -53.7% | -23.2% | 17.5% |
| Net Profit Margin | 0.4% | 0.4% | 30.6% | 29.5% | 63.6% | 62.1% | -35.2% | -14.2% | 14.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.3% | 0.3% | 9.3% | 9.5% | 60.5% | 32.5% | -19.0% | -6.5% | 25.3% |
| ROA | 0.0% | 0.0% | 0.3% | 0.3% | 1.8% | 0.9% | -0.5% | -0.2% | 0.8% |
| ROIC | -1.0% | -1.0% | 7.7% | 6.8% | 52.8% | 31.4% | -22.9% | -9.9% | 42.5% |
| ROCE | -0.0% | -0.0% | 0.3% | 0.3% | 2.2% | 1.2% | -0.9% | -0.3% | 0.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.45 | 0.45 | 0.20 | 0.39 | 0.47 | 0.37 | 0.03 | 0.37 | 0.04 |
| Debt / EBITDA | — | — | 1.81 | 3.77 | 0.56 | 0.93 | — | — | 0.14 |
| Net Debt / Equity | — | -0.11 | -0.17 | 0.13 | 0.01 | 0.13 | -0.17 | 0.10 | -0.46 |
| Net Debt / EBITDA | — | — | -1.54 | 1.25 | 0.01 | 0.33 | — | — | -1.51 |
| Debt / FCF | — | -0.19 | -0.30 | 0.25 | 0.01 | 0.25 | -0.46 | 0.17 | -0.62 |
| Interest Coverage | -0.14 | -0.14 | 11.12 | 5.77 | 69.31 | 118.43 | -27.31 | -7.19 | 28.76 |
Net cash position: cash ($5.7B) exceeds total debt ($4.6B)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.52 | 4.52 | — | 3.17 | — | — | 1.80 | — | 32.77 |
| Quick Ratio | 4.52 | 4.52 | — | 3.17 | — | — | 1.80 | — | 32.77 |
| Cash Ratio | 3.28 | 3.28 | — | 1.98 | — | — | 1.14 | — | 32.77 |
| Asset Turnover | — | 0.02 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.01 | 0.05 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.4% | 3.0% | 3.3% | 4.7% | 6.0% | 1.3% | — | — | — |
| Payout Ratio | 825.9% | 825.9% | 22.3% | 21.5% | 3.0% | 1.5% | — | — | 22.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 9.9% | — | 13.5% | 21.0% | 200.5% | 85.8% | — | — | — |
| FCF Yield | 64.1% | 76.8% | 89.4% | 124.1% | 168.7% | 153.2% | — | — | — |
| Buyback Yield | 7.2% | 8.9% | 6.8% | 7.2% | 10.4% | 5.7% | — | — | — |
| Total Shareholder Yield | 9.6% | 11.9% | 10.1% | 11.8% | 16.4% | 7.0% | — | — | — |
| Shares Outstanding | — | $70M | $74M | $84M | $89M | $89M | $94M | $94M | $94M |
Includes 30+ ratios · 8 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying JXN stock.
Jackson Financial Inc.'s current P/E ratio is 10.1x. The historical average is 3.5x. This places it at the 100th percentile of its historical range.
Jackson Financial Inc.'s current EV/EBITDA is 6.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 2.8x.
Jackson Financial Inc.'s return on equity (ROE) is 0.3%. The historical average is 14.0%.
Based on historical data, Jackson Financial Inc. is trading at a P/E of 10.1x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Jackson Financial Inc.'s current dividend yield is 2.39% with a payout ratio of 825.9%.
Jackson Financial Inc. has 85.5% gross margin and -1.7% operating margin.
Key Metrics
Top Statement Risk
Volatile reserve and hedge-driven earnings
Metrics are mathematically derived from official filings.
Sub-Book Pricing Reflects Earnings Skepticism
Based on reported figures, JXN trades at 0.90x book value against a 2026Q3 ROE of 8.9%, a pricing level that suggests investors are discounting the durability of recent profitability rather than the book itself.
A P/B below 1.0x for a life and annuity carrier implies the market expects returns on equity to remain below the cost of equity over time, and the trailing P/E of -553 reflects earnings distortion rather than a usable valuation signal. Compared with PFG at 2.05x and MET at 2.29x, the discount appears tied to the capital intensity of the legacy variable annuity book rather than to a broken franchise. Investors should monitor whether the 8.9% ROE can be sustained across multiple quarters before treating the book value as fully credible.
Combined Ratio Swings Obscure Underlying Trend
As reported in financial statements, JXN's combined ratio moved from 73.5% in 2024Q2 to 127.7% in 2024Q3 and 117.1% in 2025Q4 before reaching 102.2% in 2026Q3, a pattern that points to reserve revaluation noise more than steady underwriting change.
Loss ratios ranging from -113.5% to 109.1% across recent quarters indicate that the combined ratio is being driven by reserve and hedge adjustments rather than by pricing discipline in the core book. The most recent 102.2% reading sits just above the break-even line, which suggests underwriting is near neutral rather than generating a clear margin. Warranting further investigation is whether the 2026Q3 improvement reflects genuine loss experience or a favorable one-off reserve movement.
ROE Rests on Volatile Earnings Base
Based on JXN's reported figures, ROE has oscillated between -4.4% and 8.9% over the ten quarters shown, with the 2026Q3 reading of 8.9% sitting well above the 2025 average and above the peer median of roughly 12% only in part.
Decomposing returns, the swing from negative to high single-digit ROE appears to be driven by items such as reserve releases and hedge mark-to-market rather than by a stable investment spread on float. ROA of just 0.2% against an ROE of 8.9% implies substantial leverage in the balance sheet, which amplifies even modest earnings changes. Investors should treat the latest quarter as a potential high-water mark until the drivers are clarified.
Capital Base Thins Against Ongoing Returns
Based on JXN's reported figures, equity declined from roughly $10.7B in 2024Q3 to $8.5B in 2026Q3 while the debt-to-equity ratio rose to 0.31 from 0.46 in 2026Q1, suggesting capital return has been running against a shrinking cushion.
Liabilities at roughly 97 to 98 percent of total assets imply a highly levered balance sheet where small valuation changes in reserves or hedges can disproportionately affect equity. The falling equity base alongside continued buybacks and dividends warrants monitoring of statutory capital, which is a more reliable solvency gauge than GAAP book value for this carrier. Investors should watch whether payouts remain covered by operating cash without eroding capital adequacy.
Discount to Peers Justified by Earnings Quality
As reported in peer data, JXN's 0.90x P/B sits well below MET at 2.29x, PFG at 2.05x, and PRU at 1.20x, while its 8.9% ROE is below PFG's 15.8% and MET's 12.8%, a gap that appears consistent with the market's view of its earnings volatility.
The valuation discount is larger than ROE differences alone would explain, suggesting the market is pricing in tail risk from the variable annuity guarantee book and hedge program. Lincoln National, at 0.67x P/B, shares a similar discount, which points to a sector-wide concern about legacy VA capital intensity rather than a company-specific anomaly. Whether JXN closes this gap depends on demonstrating a durable ROE above peer medians.
Combined Ratio Ignores Reserve Development Risk
The most commonly misapplied metric for JXN is the combined ratio in isolation, since it may obscure reserve development and hedge-related obligations that the statement data shows swinging by billions across quarters.
A single-quarter combined ratio near 100% can look like underwriting break-even while masking large reserve releases in one period and deficits in another, as the claims line shifting from a $2.4B benefit to a $2.3B outflow illustrates. A more reliable alternative is to normalize combined ratio over a rolling four-quarter window and to track statutory total adjusted capital alongside GAAP ROE. Investors should treat the headline ratios as directional inputs rather than conclusive measures of underwriting quality.